Simultaneous treatment of unresectable hepatocelluar carcinoma and hepatic artery aneurysm, case report.

摘要: Hepatic artery aneurysm is uncommon with an estimated incidence of less than 0.25%. Because most patients are asymptomatic, the diagnosis usually made as incidental finding on imaging studies performed for other reasons. their propensity to rupture potential catastrophic intraperitoneal hemorrhage, early important. Herein, relatively asymptomatic common hepatic mostly atherosclerotic etiology presented. The importance findings in this condition discussed and relevant literature reviewed (1, 2). Hepatocellular carcinoma (HCC) ranks among malignancies worldwide, prognosis HCC typically poor. Chemoembolization has become mainstay treatment unresectable HCC. Transcatheter arterial chemoembolization intended deliver a highly concentrated dose chemotherapy tumor cells, prolong contact time between chemotherapeutic agents cancer minimize systemic toxicity. Ideally, achieving these goals will result shrinkage, symptomatic relief, improved quality life, increased patient survival (3). We present case male patient, 72 years old, who was referred transcatheter hepatocelluar carcinoma. Helical CT scan showed right lobe mass infiltrating peritoneum enhancement phase together that successfully treated at same using emulsion N-butyl cyanoacylate lipodol concentration 1:1. aneurysms lesions have varied clinical presentations. Early essential because natural tendency lesion into peritoneal cavity or surrounding organs. Our notable, extremely rare very few cases reported so far diagnose treat it one setting without also unusual.